This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bahl, D.
Right arrow Articles by Miller, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bahl, D.
Right arrow Articles by Miller, M. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Jun 1997, 1293-1297, Vol 41, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin- susceptible and methicillin-resistant Staphylococcus aureus

D Bahl, DA Miller, I Leviton, P Gialanella, MJ Wolin, W Liu, R Perkins and MH Miller
Department of Medicine, Albany Medical College, and Wadsworth Center for Laboratories and Research, New York 12208, USA.

We characterized the effects of ciprofloxacin and rifampin alone and in combination on Staphylococcus aureus in vitro. The effects of drug combinations (e.g., indifferent, antagonistic, or additive interactions) on growth inhibition were compared by disk approximation studies and by determining the fractional inhibitory concentrations. Bactericidal effects in log-phase bacteria and in nongrowing isolates were characterized by time-kill methods. The effect of drug combinations was dependent upon whether or not cells were growing and whether killing or growth inhibition was the endpoint used to measure drug interaction. Despite bactericidal antagonism in time-kill experiments, our in vitro studies suggest several possible explanations for the observed benefits in patients treated with a combination of ciprofloxacin and rifampin for deep-seated staphylococcal infections. Notably, when growth inhibition rather than killing was used to characterize drug interaction, indifference rather than antagonism was observed. An additive bactericidal effect was observed in nongrowing bacteria suspended in phosphate-buffered saline. While rifampin antagonized the bactericidal effects of ciprofloxacin, ciprofloxacin did not antagonize the bactericidal effects of rifampin. Each antimicrobial prevented the emergence of subpopulations that were resistant to the other.


This article has been cited by other articles:

  • Murillo, O., Pachon, M. E., Euba, G., Verdaguer, R., Tubau, F., Cabellos, C., Cabo, J., Gudiol, F., Ariza, J. (2008). Antagonistic Effect of Rifampin on the Efficacy of High-Dose Levofloxacin in Staphylococcal Experimental Foreign-Body Infection. Antimicrob. Agents Chemother. 52: 3681-3686 [Abstract] [Full Text]  
  • Perlroth, J., Kuo, M., Tan, J., Bayer, A. S., Miller, L. G. (2008). Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections: A Systematic Review of the Literature. Arch Intern Med 168: 805-819 [Abstract] [Full Text]  
  • Soriano, A., Ortega, M., Garcia, S., Penarroja, G., Bove, A., Marcos, M., Martinez, J. C., Martinez, J. A., Mensa, J. (2007). Comparative Study of the Effects of Pyridoxine, Rifampin, and Renal Function on Hematological Adverse Events Induced by Linezolid. Antimicrob. Agents Chemother. 51: 2559-2563 [Abstract] [Full Text]  
  • Murillo, O., Domenech, A., Garcia, A., Tubau, F., Cabellos, C., Gudiol, F., Ariza, J. (2006). Efficacy of High Doses of Levofloxacin in Experimental Foreign-Body Infection by Methicillin-Susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 50: 4011-4017 [Abstract] [Full Text]  
  • Seral, C., Van Bambeke, F., Tulkens, P. M. (2003). Quantitative Analysis of Gentamicin, Azithromycin, Telithromycin, Ciprofloxacin, Moxifloxacin, and Oritavancin (LY333328) Activities against Intracellular Staphylococcus aureus in Mouse J774 Macrophages. Antimicrob. Agents Chemother. 47: 2283-2292 [Abstract] [Full Text]  
  • Osmon, D. R. (2001). Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon. JBJS 83: 1891-1901 [Full Text]  
  • Ouadrhiri, Y., Scorneaux, B., Sibille, Y., Tulkens, P. M. (1999). Mechanism of the Intracellular Killing and Modulation of Antibiotic Susceptibility of Listeria monocytogenes in THP-1 Macrophages Activated by Gamma Interferon. Antimicrob. Agents Chemother. 43: 1242-1251 [Abstract] [Full Text]